EP0503055A4 - - Google Patents

Info

Publication number
EP0503055A4
EP0503055A4 EP19910918631 EP91918631A EP0503055A4 EP 0503055 A4 EP0503055 A4 EP 0503055A4 EP 19910918631 EP19910918631 EP 19910918631 EP 91918631 A EP91918631 A EP 91918631A EP 0503055 A4 EP0503055 A4 EP 0503055A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910918631
Other versions
EP0503055A1 (en
Inventor
Willem Van Eden
Marca H.M. Wauben
Ruurd Van Der Zee
Claire J. P. Boog
Irun R. Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Nederlanden Welzijn Volksgezondheid en Cultuur Minister van
Rijksuniversiteit Utrecht
Original Assignee
Yeda Research and Development Co Ltd
Nederlanden Welzijn Volksgezondheid en Cultuur Minister van
Rijksuniversiteit Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd, Nederlanden Welzijn Volksgezondheid en Cultuur Minister van, Rijksuniversiteit Utrecht filed Critical Yeda Research and Development Co Ltd
Publication of EP0503055A1 publication Critical patent/EP0503055A1/en
Publication of EP0503055A4 publication Critical patent/EP0503055A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP91918631A 1990-09-06 1991-09-05 Inhibitor of lymphocyte response and immune-related disease Withdrawn EP0503055A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57850690A 1990-09-06 1990-09-06
US578506 1990-09-06

Publications (2)

Publication Number Publication Date
EP0503055A1 EP0503055A1 (en) 1992-09-16
EP0503055A4 true EP0503055A4 (xx) 1994-02-16

Family

ID=24313172

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91918631A Withdrawn EP0503055A1 (en) 1990-09-06 1991-09-05 Inhibitor of lymphocyte response and immune-related disease

Country Status (8)

Country Link
EP (1) EP0503055A1 (xx)
JP (1) JPH05507501A (xx)
AU (1) AU650065B2 (xx)
CA (1) CA2071896A1 (xx)
IL (1) IL99429A0 (xx)
NZ (1) NZ239699A (xx)
WO (1) WO1992004049A1 (xx)
ZA (1) ZA917097B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705108A4 (en) * 1993-06-02 1997-08-06 Tvw Telethon Inst Child Health USE OF CRYPTIC PEPTIDES FOR INDUCTION IMMUNOLOGICAL TOLERANCE
AU699007B2 (en) * 1994-03-21 1998-11-19 Rijksuniversiteit Utrecht Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
IT1271074B (it) * 1994-11-21 1997-05-26 Italfarmaco Spa Peptidi ad attivita' antiinfiammatoria
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US5993803A (en) * 1996-08-30 1999-11-30 Yeda Research And Development Co., Ltd. Method of reducing the severity of host vs graft reaction by down-regulating hsp60 autoimmunity
IL131025A0 (en) * 1997-01-24 2001-01-28 Autoimmune Inc Treatment of autoimmune disease using tolerization in combination with methotrexate
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
ES2526822T3 (es) 2002-01-31 2015-01-15 Andromeda Bio Tech Ltd. Péptidos hsp y análogos para la modulación de respuestas inmunes mediante células presentadoras de antígeno
ES2389301T3 (es) 2002-05-21 2012-10-25 Irun R. Cohen Vacunas de ADN que codifican proteínas de choque térmico
EP1835933A4 (en) 2005-01-04 2015-01-07 Yeda Res & Dev HSP60, PEPTIDES HSP60 AND T-CELL VACCINES FOR IMMUNOMODULATION

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BEN-NUN ET AL: "EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) MEDIATED BY T CELL LINES:PROCESS OF SELECTION OF LINES AND CHARACTERIZATION OF THE CELLS", THE JOURNAL OF IMMUNOLOGY, vol. 129, 1982, BALTIMORE,USA, pages 303 - 308 *
DUNKLEY ET AL: "AMINO ACID SEQUENCE OF THE SMALLER BASIC PROTEIN FROM RAT BRAIN MYELIN", THE BIOCHEMICAL JOURNAL, vol. 141, 1974, LONDON,GB, pages 243 - 255 *
MANNIE ET AL: "ENCEPHALITOGENIC AND PROLIFERATIVE RESPONSES OF LEWIS RAT LYMPHOCYTES DISTUINGUISHED BY POSITION 75- AND 80-SUBSTITUTED PEPTIDES OF MYELIN BASIC PROTEIN", THE JOURNAL OF IMMUNOLOGY, vol. 142, 1989, BALTIMORE,USA, pages 2608 - 2616, XP002207806 *
SCHAICH ET AL: "CLONED PROTEOLIPID PROTEIN AND MYELIN BASIC PROTEIN CDNA", BIOLOGICAL CHEMISTRY HOPPE-SEYLER, vol. 367, 1986, BERLIN,DE, pages 825 - 834, XP008009587 *
See also references of WO9204049A1 *

Also Published As

Publication number Publication date
ZA917097B (en) 1992-09-30
JPH05507501A (ja) 1993-10-28
NZ239699A (en) 1993-11-25
IL99429A0 (en) 1992-08-18
EP0503055A1 (en) 1992-09-16
CA2071896A1 (en) 1992-03-07
WO1992004049A1 (en) 1992-03-19
AU650065B2 (en) 1994-06-09
AU8755991A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
FR2659604B1 (xx)
FR2661643B1 (xx)
FR2671197B1 (xx)
DE4191952T1 (xx)
IN171616B (xx)
FR2663985B1 (xx)
FR2670543B1 (xx)
FR2665536B1 (xx)
DE4190714T (xx)
FR2662789B1 (xx)
FR2660781B1 (xx)
FR2668928B1 (xx)
DE4192257T (xx)
FR2667981B1 (xx)
FR2670660B1 (xx)
FR2659741B1 (xx)
DK0465677T3 (xx)
FR2670807B1 (xx)
FR2668439B1 (xx)
FR2657124B1 (xx)
FR2668576B1 (xx)
FR2668402B1 (xx)
IN171538B (xx)
FR2669255B1 (xx)
FR2668822B1 (xx)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920505

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C07K 7/06

A4 Supplementary search report drawn up and despatched

Effective date: 19931227

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960401